Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Marta Pelczyńska, Ewa Miller-Kasprzak, Marcin Piątkowski, Roksana Mazurek, Mateusz Klause, Anna Suchecka, Magdalena Bucoń & Paweł Bogdański. (2023) The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes—New Perspectives. Antioxidants 12:12, pages 2046.
Crossref
Crossref
Saleh Rahmati, Behnam Mohammadi, Zahra Karimi‐Mehr & David Robert Broom. (2023) Effects of physical activity and exercise on Nucleobindin‐2 gene expression and Nesfatin‐1 concentration: A rapid review. Cell Biochemistry and Function.
Crossref
Crossref
Mohammed S . MahmudLamia S. Ashoor. (2023) Nesfatin-1 is a biomarker that plays a role in the inflammatory
process of coronary artery diseases in Iraqi patients with
non-alcoholic fatty liver disease.. Bionatura 8:CSS 3, pages 1-8.
Crossref
Crossref
Anca D. Petrescu, Su Yeon An, Juliet Venter, Matthew McMillin & Sharon DeMorrow. (2023) The Role of Hypothalamic Neuropeptides in Regulation of Liver Functions in Health and Disease. Endocrines 4:2, pages 457-487.
Crossref
Crossref
Smaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, Marina Boziki, Stergios A. Polyzos, Maria Tzitiridou, Dimitrios Chatzopoulos, Tharshika Thavayogarajah, Ioanna Gkolia, Georgios Ntonas, Elisabeth Vardaka & Michael Doulberis. (2023) Impact of nonalcoholic fatty liver disease-related metabolic state on depression. Neurochemistry International 163, pages 105484.
Crossref
Crossref
Jing-jing Luo, Feng-jiao Wen, Dan Qiu & Shu-zhi Wang. (2021) Nesfatin-1 in lipid metabolism and lipid-related diseases. Clinica Chimica Acta 522, pages 23-30.
Crossref
Crossref
Krittika Dotania, Mamta Tripathy & Umesh Rai. (2021) A comparative account of nesfatin-1 in vertebrates. General and Comparative Endocrinology 312, pages 113874.
Crossref
Crossref
Talat AYYILDIZ, Enver DOLAR, Barbaros ORAL, Şener ARIKAN & Saduman BALABAN. (2021) Non-alcoholic Fatty Liver Disease and Its Association with Serum Nesfatin- 1Non-Alkolik Yağlı Karaciğer Hastalığı Ve Serum Nesfatin-1 İlişkisi. Anadolu Kliniği Tıp Bilimleri Dergisi 26:1, pages 45-53.
Crossref
Crossref
Geng Wang, Qingbo Wang, Jie Bai, Gang Li, Kaixiong Tao, Guobin Wang & Zefeng Xia. (2020) RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment. PLOS ONE 15:12, pages e0243640.
Crossref
Crossref
Saber Jafari-Maskouni, Mansour Shahraki, Milad Daneshi-Maskooni, Alireza Dashipour, Ali Shamsi-Goushki & Zinat Mortazavi. (2020) Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial. Nutrition & Metabolism 17:1.
Crossref
Crossref
Tuba Tekin, Betül Çiçek, Nurefşan Konyalıgil, İnayet Güntürk, Cevat Yazıcı, Züleyha Karaca & Meltem Ünlüsavuran. (2020) Increased hip circumference in individuals with metabolic syndrome affects serum nesfatin-1 levels. Postgraduate Medical Journal 96:1140, pages 600-605.
Crossref
Crossref
Qingbo Wang, Yongming Huang, Rui Zhou, Ke Wu, Wei Li, Liang Shi, Zefeng Xia, Kaixiong Tao, Guobin Wang & Geng Wang. (2019) Regulation and function of IL‐22 in peritoneal adhesion formation after abdominal surgery. Wound Repair and Regeneration 28:1, pages 105-117.
Crossref
Crossref
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni & Mohammad-Javad Hosseinzadeh-Attar. (2019) Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. Nutrition & Metabolism 16:1.
Crossref
Crossref
Hayriye BAYKAN. (2019) Plasma Nesfatin-1 Levels and its Relationship With Anxiety Levels in Obesity Diagnosed Population: A Controlled Study. Clinical and Experimental Health Sciences.
Crossref
Crossref
Martha A Schalla & Andreas Stengel. (2018) Current Understanding of the Role of Nesfatin-1. Journal of the Endocrine Society 2:10, pages 1188-1206.
Crossref
Crossref
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni & Mohammad-Javad Hosseinzadeh-Attar. (2017) Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. BMJ Open 7:7, pages e016914.
Crossref
Crossref
Philip Prinz & Andreas Stengel. (2016) Nesfatin-1: current status as a peripheral hormone and future prospects. Current Opinion in Pharmacology 31, pages 19-24.
Crossref
Crossref
Sandra Feijóo-Bandín, Diego Rodríguez-Penas, Vanessa García-Rúa, Ana Mosquera-Leal, José Ramón González-Juanatey & Francisca Lago. (2015) Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level. Endocrine 52:1, pages 11-29.
Crossref
Crossref
Yue Yin, Ziru Li, Ling Gao, Yin Li, Jing Zhao & Weizhen Zhang. (2015) AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1. Molecular and Cellular Endocrinology 417, pages 20-26.
Crossref
Crossref
Tobias Hofmann, Ulf Elbelt, Anne Ahnis, Matthias Rose, Burghard F. Klapp & Andreas Stengel. (2015) Sex-specific regulation of NUCB2/nesfatin-1: Differential implication in anxiety in obese men and women. Psychoneuroendocrinology 60, pages 130-137.
Crossref
Crossref
Andreas Stengel. (2015) Nesfatin-1 – More than a food intake regulatory peptide. Peptides 72, pages 175-183.
Crossref
Crossref
Tobias Hofmann, Anne Ahnis, Ulf Elbelt, Matthias Rose, Burghard F. Klapp & Andreas Stengel. (2015) NUCB2/nesfatin-1 Is Associated with Elevated Levels of Anxiety in Anorexia Nervosa. PLOS ONE 10:7, pages e0132058.
Crossref
Crossref
Yongfang Guo, Mingqing Xing, Wenjuan Sun, Xiaoyan Yuan, Hongyan Dai & Huamin Ding. (2018) Plasma Nesfatin-1 Level in Obese Patients after Acupuncture: A Randomised Controlled Trial. Acupuncture in Medicine 32:4, pages 313-317.
Crossref
Crossref
Sandra Feijóo-Bandín, Diego Rodríguez-Penas, Vanessa García-Rúa, Ana Mosquera-Leal, Manuel Francisco Otero, Eva Pereira, José Rubio, Isabel Martínez, Luisa María Seoane, Oreste Gualillo, Manuel Calaza, Tomás García-Caballero, Manuel Portolés, Esther Roselló-Lletí, Carlos Diéguez, Miguel Rivera, José Ramón González-Juanatey & Francisca Lago. (2013) Nesfatin-1 in Human and Murine Cardiomyocytes: Synthesis, Secretion, and Mobilization of GLUT-4. Endocrinology 154:12, pages 4757-4767.
Crossref
Crossref
Bulent Bahceci, Erman Bagcioglu, Aziz Ramazan Dilek, Fatmagul Helvaci Celik, İlkay Bahçeci & Ahmet Hakki Asik. (2013) The role of nesfatin-1 in impaired appetite in patients with major depressive disorder. Neurology, Psychiatry and Brain Research 19:4, pages 192-196.
Crossref
Crossref
A. Stengel, M. Mori & Y. Taché. (2013) The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors. Obesity Reviews 14:11, pages 859-870.
Crossref
Crossref
Suleyman Aydin. (2013) Multi-functional peptide hormone NUCB2/nesfatin-1. Endocrine 44:2, pages 312-325.
Crossref
Crossref
Xun Cao, Xiao-Min Liu & Li-Hong Zhou. (2013) Recent progress in research on the distribution and function of NUCB2/Nesfatin-1 in peripheral tissues [Review]. Endocrine Journal 60:9, pages 1021-1027.
Crossref
Crossref